July 19, 2021 at 5:00 PM CT

COVID-19 national public health emergency extension

The U.S. Department of Health and Human Services has extended the COVID-19 national public health emergency by another 90 days. It was scheduled to end July 19, 2021 and now is scheduled through Oct. 17, 2021. The Summary of COVID-19 Temporary Program ProvisionsCOVID-19 Billing Guide and UHCprovider.com/COVID19 web pages have been updated to reflect this extension.

COVID-19 Vaccines

Last update: May 13, 2021, 10:50 a.m. CT

UPDATE: Johnson & Johnson (Janssen) COVID-19 Vaccine

April 23, 2021

The use of Johnson & Johnson’s Janssen COVID-19 vaccine has resumed, effective April 23, 2021. The Centers for Disease Control and Prevention (CDC) and the U.S. Food and Drug Administration (FDA) state that women younger than 50 years old should be aware of the rare risk of blood clots with low platelets after vaccination. Other COVID-19 vaccines, such as Pfizer and Moderna, are available where this risk has not been seen. The Janssen COVID-19 Vaccine Fact Sheets for healthcare providers and patients have been updated to include information about this very rare and serious type of blood clot. Additional details on the Janssen COVID-19 vaccine can be found on the CDC website.

Vaccine Confidence resources

Our COVID-19 vaccine confidence section has or more information and resources to help answering patient questions regarding the COVID-19 vaccines. 

New! COVID-19 Vaccine Reimbursement and Billing Overview

This course provides information on COVID-19 administration, billing, reimbursement and resources. It may be most beneficial to CDC COVID-19 vaccination program providers. 


The benefits and processes described on this website apply pursuant to federal requirements and UnitedHealthcare national policy during the national emergency.  Additional benefits or limitations may apply in some states and under some plans during this time.

We will adjudicate benefits in accordance with the member’s health plan.

Medicaid Providers: UnitedHealthcare will reimburse out-of-network providers for COVID-19 testing-related visits and COVID-19 related treatment or services according to the rates outlined in the Medicaid Fee Schedule.